Farmaceutiske midler

The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-met hoxybenzoyl]-2-methylbenzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and anothe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: EDWARDS, IEUAN JOHN, BRADWAY, RANDY JOHN, TIMKO, ROBERT JOSEPH, CLEMENTS, ARLENE, HOLOHAN, JAMES JOSEPH
Format: Patent
Sprache:dan
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator EDWARDS, IEUAN JOHN
BRADWAY, RANDY JOHN
TIMKO, ROBERT JOSEPH
CLEMENTS, ARLENE
HOLOHAN, JAMES JOSEPH
description The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-met hoxybenzoyl]-2-methylbenzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-met hoxybenzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK0490648TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK0490648TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK0490648TT33</originalsourceid><addsrcrecordid>eNrjZBBxSyzKTUxOLS3JLM5OVcjNTMlJLeJhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBUD1eakl8S7eBiaWBmYmFiEhxsbEqAEAYQwhSg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Farmaceutiske midler</title><source>esp@cenet</source><creator>EDWARDS, IEUAN JOHN ; BRADWAY, RANDY JOHN ; TIMKO, ROBERT JOSEPH ; CLEMENTS, ARLENE ; HOLOHAN, JAMES JOSEPH</creator><creatorcontrib>EDWARDS, IEUAN JOHN ; BRADWAY, RANDY JOHN ; TIMKO, ROBERT JOSEPH ; CLEMENTS, ARLENE ; HOLOHAN, JAMES JOSEPH</creatorcontrib><description>The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-met hoxybenzoyl]-2-methylbenzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-met hoxybenzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.</description><edition>5</edition><language>dan</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1996</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19960506&amp;DB=EPODOC&amp;CC=DK&amp;NR=0490648T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19960506&amp;DB=EPODOC&amp;CC=DK&amp;NR=0490648T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>EDWARDS, IEUAN JOHN</creatorcontrib><creatorcontrib>BRADWAY, RANDY JOHN</creatorcontrib><creatorcontrib>TIMKO, ROBERT JOSEPH</creatorcontrib><creatorcontrib>CLEMENTS, ARLENE</creatorcontrib><creatorcontrib>HOLOHAN, JAMES JOSEPH</creatorcontrib><title>Farmaceutiske midler</title><description>The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-met hoxybenzoyl]-2-methylbenzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-met hoxybenzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1996</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBxSyzKTUxOLS3JLM5OVcjNTMlJLeJhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBUD1eakl8S7eBiaWBmYmFiEhxsbEqAEAYQwhSg</recordid><startdate>19960506</startdate><enddate>19960506</enddate><creator>EDWARDS, IEUAN JOHN</creator><creator>BRADWAY, RANDY JOHN</creator><creator>TIMKO, ROBERT JOSEPH</creator><creator>CLEMENTS, ARLENE</creator><creator>HOLOHAN, JAMES JOSEPH</creator><scope>EVB</scope></search><sort><creationdate>19960506</creationdate><title>Farmaceutiske midler</title><author>EDWARDS, IEUAN JOHN ; BRADWAY, RANDY JOHN ; TIMKO, ROBERT JOSEPH ; CLEMENTS, ARLENE ; HOLOHAN, JAMES JOSEPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK0490648TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>1996</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>EDWARDS, IEUAN JOHN</creatorcontrib><creatorcontrib>BRADWAY, RANDY JOHN</creatorcontrib><creatorcontrib>TIMKO, ROBERT JOSEPH</creatorcontrib><creatorcontrib>CLEMENTS, ARLENE</creatorcontrib><creatorcontrib>HOLOHAN, JAMES JOSEPH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>EDWARDS, IEUAN JOHN</au><au>BRADWAY, RANDY JOHN</au><au>TIMKO, ROBERT JOSEPH</au><au>CLEMENTS, ARLENE</au><au>HOLOHAN, JAMES JOSEPH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Farmaceutiske midler</title><date>1996-05-06</date><risdate>1996</risdate><abstract>The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-met hoxybenzoyl]-2-methylbenzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-met hoxybenzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language dan
recordid cdi_epo_espacenet_DK0490648TT3
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Farmaceutiske midler
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A03%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=EDWARDS,%20IEUAN%20JOHN&rft.date=1996-05-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK0490648TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true